Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1%

Clinical trial NCT02236403 · COMPLETED

Trial details

NCT number: NCT02236403
Sponsor: Universidad Nacional de Colombia
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Blepharitis

Start date: 2014-10-01
Primary completion: 2015-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.